Search Results - "SIDELNIKOV, Eduard"

Refine Results
  1. 1

    Effects of Supplemental Vitamin D and Calcium on Oxidative DNA Damage Marker in Normal Colorectal Mucosa: A Randomized Clinical Trial by FEDIRKO, Veronika, BOSTICK, Roberd M, QI LONG, DANA FLANDERS, W, MCCULLOUGH, Marjorie L, SIDELNIKOV, Eduard, DANIEL, Carrie R, RUTHERFORD, Robin E, SHAUKAT, Aasma

    “…The exact antineoplastic effects of calcium and vitamin D 3 in the human colon are unclear. Animal and in vitro studies show that these two agents reduce…”
    Get full text
    Journal Article
  2. 2

    Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK by Danese, Mark, Sidelnikov, Eduard, Villa, Guillermo, Catterick, David, Iqbal, Mazhar, Gleeson, Michelle, Lubeck, Deborah, Patel, Jeetesh

    Published in BMJ open (29-04-2022)
    “…ObjectivesTo compare treatment patterns, risk factors and cardiovascular disease (CVD) event rates in the UK from 2008 to 2017.DesignRetrospective cohort study…”
    Get full text
    Journal Article
  3. 3

    Effects of Vitamin D and Calcium on Proliferation and Differentiation In Normal Colon Mucosa: a Randomized Clinical Trial by FEDIRKO, Veronika, BOSTICK, Roberd M, DANA FLANDERS, W, QI LONG, SIDELNIKOV, Eduard, SHAUKAT, Aasma, DANIEL, Carrie R, RUTHERFORD, Robin E, JOELLE WOODARD, Jill

    “…To investigate the potential efficacy of calcium and vitamin D in reducing risk for colorectal neoplasms and to develop “treatable” phenotypic biomarkers of…”
    Get full text
    Journal Article
  4. 4

    Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal by Marques, Nuno, Gerlier, Laetitia, Ramos, Mafalda, Pereira, Helder, Rocha, Sérgia, Fonseca, Ana Catarina, André, Ana, Melo, Ricardo, Sidelnikov, Eduard

    Published in Revista portuguesa de cardiologia (01-02-2021)
    “…To present the Portuguese results of a multi-country cross-sectional survey aiming to estimate productivity loss in the first year after an acute coronary…”
    Get full text
    Journal Article
  5. 5

    TGF-α Expression as a Potential Biomarker of Risk Within the Normal-appearing Colorectal Mucosa of Patients with and without Incident Sporadic Adenoma by Daniel, Carrie R, Bostick, Roberd M, Flanders, William Dana, Long, Qi, Fedirko, Veronika, Sidelnikov, Eduard, Seabrook, March E

    “…Background: Transforming growth factor-α (TGF-α), a stimulatory growth factor and member of the epidermal growth factor family, is a mediator of oncogenesis…”
    Get full text
    Journal Article
  6. 6

    Colorectal Mucosal Expression of MSH2 as a Potential Biomarker of Risk for Colorectal Neoplasms by SIDELNIKOV, Eduard, BOSTICK, Roberd M, DANA FLANDERS, W, QI LONG, SEABROOK, March E

    “…To characterize the expression of the mismatch repair gene MSH2 in normal colorectal crypts in humans and assess parameters of its expression as a potential…”
    Get full text
    Journal Article
  7. 7

    MutL-Homolog 1 Expression and Risk of Incident, Sporadic Colorectal Adenoma: Search for Prospective Biomarkers of Risk for Colorectal Cancer by SIDELNIKOV, Eduard, BOSTICK, Roberd M, DANA FLANDERS, W, QI LONG, COHEN, Vaunita L, DASH, Chiranjeev, SEABROOK, March E, FEDIRKO, Veronika

    “…To characterize the expression of the mismatch repair gene MutL-homolog 1 ( MLH1 ) in normal colorectal crypts in humans, and assess parameters of its…”
    Get full text
    Journal Article
  8. 8

    Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe by Kotseva, Kornelia, Gerlier, Laetitia, Sidelnikov, Eduard, Kutikova, Lucie, Lamotte, Mark, Amarenco, Pierre, Annemans, Lieven

    Published in European journal of preventive cardiology (01-07-2019)
    “…Aims The aim of this study was to estimate patient and caregiver productivity loss and indirect costs following an acute coronary syndrome (ACS) or a stroke in…”
    Get full text
    Journal Article
  9. 9

    Abstract 10160: Population Eligible for PCSK9i in Spain: A Real-World Analysis by Cosin Sales, Juan, Sidelnikov, Eduard, Villamayor Galli, Santiago, Fernandez Delgado, Miriam, Torres Romero, Elena, Zamora, Alberto

    Published in Circulation (New York, N.Y.) (16-11-2021)
    “…BackgroundCardiovascular (CV) diseases are the leading cause of mortality globally. Reducing low-density lipoprotein cholesterol (LDL-C) is a proven strategy…”
    Get full text
    Journal Article
  10. 10

    Abstract 4136273: A Machine Learning Approach to Simplify Risk Stratification of Patients with Atherosclerotic Cardiovascular Disease by Li, Hsin Fang, Nute, Andrew, Weerasinghe, Roshanthi, Wendt, Staci, Wilson, Eleni, Sidelnikov, Eduard, Kathe, Niranjan, Swihart, Charissa, Jones, Laney, Gluckman, Ty

    Published in Circulation (New York, N.Y.) (12-11-2024)
    “…Abstract only Introduction: The 2018 AHA/ACC/Multisociety Blood Cholesterol Guideline recommends that patients with atherosclerotic cardiovascular disease…”
    Get full text
    Journal Article
  11. 11

    Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany by Ahrens, Ingo, Khachatryan, Artak, Monga, Bondo, Dornstauder, Eugen, Sidelnikov, Eduard

    Published in Advances in therapy (01-05-2021)
    “…Introduction Patients with a history of myocardial infarction (MI) are at very high risk of subsequent cardiovascular events. This study evaluated the…”
    Get full text
    Journal Article
  12. 12

    The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very high risk of cardiovascular events in the United Kingdom: a cross-sectional study by Danese, Mark D., Sidelnikov, Eduard, Kutikova, Lucie

    Published in Current medical research and opinion (03-08-2018)
    “…Objective: To assess the prevalence of patients at very high risk of cardiovascular (CV) events in the United Kingdom (UK) and evaluate low-density lipoprotein…”
    Get full text
    Journal Article
  13. 13

    Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain by Cosin-Sales, Juan, Sidelnikov, Eduard, Villamayor, Santiago, Fernández, Miriam, Merino-Montero, Sandra, Zamora, Alberto

    Published in Advances in therapy (01-06-2023)
    “…Introduction Many patients at very high risk of cardiovascular (CV) events would benefit from lipid-lowering therapies (LLT) intensification to decrease their…”
    Get full text
    Journal Article
  14. 14

    Rates of Lipid Testing among Patients with Atherosclerotic Cardiovascular Disease within a Large Community-Based Health System by Li, Hsin-Fang, Weerasinghe, Roshanthi, Wendt, Staci, Sidelnikov, Eduard, Kalich, Bethany, Kathe, Niranjan, Gluckman, Tyler, Nute, Andrew

    Published in Journal of clinical lipidology (01-07-2024)
    “…This study was sponsored by Amgen, Inc., Thousand Oaks, California. Current American College of Cardiology/American Heart Association (ACC/AHA) guidelines for…”
    Get full text
    Journal Article
  15. 15

    Effect of Cardiovascular Training on Fitness and Perceived Disease Activity in People With Ankylosing Spondylitis by Niedermann, Karin, Sidelnikov, Eduard, Muggli, Claudia, Dagfinrud, Hanne, Hermann, Matthias, Tamborrini, Giorgio, Ciurea, Adrian, Bischoff‐Ferrari, Heike

    Published in Arthritis care & research (2010) (01-11-2013)
    “…Objective Several studies suggest that patients with ankylosing spondylitis (AS) have an increased risk of cardiovascular disease. This study aimed to evaluate…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Healthcare Resource Utilization, Cardiovascular Event Rate and Use of Lipid-Lowering Therapies in Secondary Prevention of ASCVD in Hospitalized Patients in Italy by Sciattella, Paolo, Maggioni, Aldo P., Arcangeli, Emanuela, Sidelnikov, Eduard, Kahangire, Doreen A., Mennini, Francesco S.

    Published in Advances in therapy (01-01-2022)
    “…Introduction Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality in Italy, accounting for 22% of total deaths. Lowering…”
    Get full text
    Journal Article
  19. 19
  20. 20